Latest & greatest articles for Wart Treatment

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on Wart Treatment or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on Wart Treatment and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for Wart Treatment

1. Topical Cantharidin/ Salicylic Acid/ Podophyllin for the Treatment of Warts: Clinical Effectiveness and Guidelines

Topical Cantharidin/ Salicylic Acid/ Podophyllin for the Treatment of Warts: Clinical Effectiveness and Guidelines Topical Cantharidin/ Salicylic Acid/ Podophyllin for the Treatment of Warts: Clinical Effectiveness and Guidelines | CADTH.ca Find the information you need Topical Cantharidin/ Salicylic Acid/ Podophyllin for the Treatment of Warts: Clinical Effectiveness and Guidelines Topical Cantharidin/ Salicylic Acid/ Podophyllin for the Treatment of Warts: Clinical Effectiveness (...) and Guidelines Last updated: January 21, 2019 Project Number: RA1006-000 Product Line: Research Type: Drug Report Type: Reference List Result type: Report Question What is the comparative clinical effectiveness of topical cantharidin/salicylic acid/podophyllin versus other topical treatments for warts? What are the evidence-based guidelines for the topical treatment of warts? Key Message One non-randomized study and two evidence-based guidelines were identified regarding topical cantharidin/ salicylic acid

2019 Canadian Agency for Drugs and Technologies in Health - Rapid Review

2. Oral cimetidine as the treatment of common warts

Oral cimetidine as the treatment of common warts Oral cimetidine as the treatment of common warts – Morsels of Evidence \t\t\t\r\n\t\t\t \t\t\t\r\n\t\t\t Share this: Like this: Like Loading... ","author":{"@type":"Person","name":"Michael Tam"},"image":["https:\/\/evidencebasedmedicine.com.au\/wp-content\/uploads\/2019\/01\/MO-DecJan2019cover.png"]} Toggle search form Toggle navigation Evidence-based medicine for general practitioners Jan 07 2019 Oral cimetidine as the treatment of common warts (...) By in , 7 January 2019 Journal reference: Yilmaz E, Alpsoy E, Basaran E. Cimetidine therapy for warts: a placebo-controlled, double-blind study. J Am Acad Dermatol 1996 Jun;34(6):1005-7 Link: Published: June 1996 Evidence cookie says… The limited research evidence does not support the use of oral cimetidine as the treatment of common warts anecdotal evidence of major benefits are not seen in blinded randomised trials although cimetidine is often seen as benign, side-effects were reported in a fifth

2019 Morsels of Evidence

3. Imiquimod for the Treatment of Genital Warts: A Review of Clinical Effectiveness and Cost-Effectiveness

Imiquimod for the Treatment of Genital Warts: A Review of Clinical Effectiveness and Cost-Effectiveness Imiquimod for the Treatment of Genital Warts: A Review of Clinical Effectiveness and Cost-Effectiveness | CADTH.ca Find the information you need Imiquimod for the Treatment of Genital Warts: A Review of Clinical Effectiveness and Cost-Effectiveness Imiquimod for the Treatment of Genital Warts: A Review of Clinical Effectiveness and Cost-Effectiveness Published on: September 25, 2017 Project (...) Number: RC0930-000 Product Line: Research Type: Drug Report Type: Summary with Critical Appraisal Result type: Report Question What is the clinical effectiveness of imiquimod for the treatment of genital warts? What is the cost-effectiveness of imiquimod for the treatment of genital warts? Key Message Evidence from systematic reviews with low quality included studies suggests that overall for patients with anogenital warts (AGW) compared to placebo, treatment with imiquimod (IMQ) is associated

2017 Canadian Agency for Drugs and Technologies in Health - Rapid Review

4. Green tea leaf extract (Veregen) - an aggressive topical treatment for anogenital warts

Green tea leaf extract (Veregen) - an aggressive topical treatment for anogenital warts Prescrire IN ENGLISH - Spotlight ''In the April issue of Prescrire International: Green tea leaf extract (Veregen°) - an aggressive topical treatment for anogenital warts'', 1 April 2015 {1} {1} {1} | | > > > In the April issue of Prescrire International: Green tea leaf extract (Veregen°) - an aggressive topical treatment for anogenital warts Spotlight Every month, the subjects in Prescrire’s Spotlight. 100 (...) most recent :  |   |   |   |   |   |   |   |   |  Spotlight In the April issue of Prescrire International: Green tea leaf extract (Veregen°) - an aggressive topical treatment for anogenital warts FREE DOWNLOAD In this sample page from the New Products section: while drugs obtained from plants have the reputation of being innocuous, they sometimes provoke serious adverse effects. Full text available for free download. Summary

2015 Prescrire

5. Imiquimod for the Treatment of External Genital Warts in Adults: Clinical and Cost-effectiveness

Imiquimod for the Treatment of External Genital Warts in Adults: Clinical and Cost-effectiveness Disclaimer: The Rapid Response Service is an information service for those involved in planning and providing health care in Canada. Rapid responses are based on a limited literature search and are not comprehensive, systematic reviews. The intent is to provide a list of sources of the best evidence on the topic that CADTH could identify using all reasonable efforts within the time allowed. Rapid (...) of External Genital Warts in Adults: Clinical and Cost-effectiveness DATE: 07 December 2012 RESEARCH QUESTIONS 1. What is the clinical evidence of the benefits and harms of 5% imiquimod for the treatment of external genital warts? 2. What is the evidence of the cost-effectiveness of 5% imiquimod for the treatment of external genital warts KEY MESSAGE One systematic review, two meta-analyses, three randomized controlled trials, three non- randomized studies, and two economic evaluations were identified

2013 Canadian Agency for Drugs and Technologies in Health - Rapid Review

6. Randomised controlled trial: Cryotherapy for plantar warts more costly but no more effective than salicylic acid self-treatment

Randomised controlled trial: Cryotherapy for plantar warts more costly but no more effective than salicylic acid self-treatment Cryotherapy for plantar warts more costly but no more effective than salicylic acid self-treatment | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username (...) and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Cryotherapy for plantar warts more costly but no more effective than salicylic acid self-treatment Article Text Therapeutics Randomised controlled trial Cryotherapy

2012 Evidence-Based Medicine

7. Cryotherapy versus salicylic acid for the treatment of plantar warts (verrucae): a randomised controlled trial. Full Text available with Trip Pro

Cryotherapy versus salicylic acid for the treatment of plantar warts (verrucae): a randomised controlled trial. To compare the clinical effectiveness of cryotherapy versus salicylic acid for the treatment of plantar warts.A multicentre, open, two arm randomised controlled trial.University podiatry school clinics, NHS podiatry clinics, and primary care in England, Scotland, and Ireland.240 patients aged 12 years and over, with a plantar wart that in the opinion of the healthcare professional (...) was suitable for treatment with both cryotherapy and salicylic acid.Cryotherapy with liquid nitrogen delivered by a healthcare professional, up to four treatments two to three weeks apart. Patient self treatment with 50% salicylic acid (Verrugon) daily up to a maximum of eight weeks.Complete clearance of all plantar warts at 12 weeks. Secondary outcomes were (a) complete clearance of all plantar warts at 12 weeks controlling for age, whether the wart had been treated previously, and type of wart, (b

2011 BMJ Controlled trial quality: predicted high

8. Local hyperthermia at 44 degrees C for the treatment of plantar warts: a randomized, patient-blinded, placebo-controlled trial Full Text available with Trip Pro

Local hyperthermia at 44 degrees C for the treatment of plantar warts: a randomized, patient-blinded, placebo-controlled trial There have been anecdotal reports that local hyperthermia was effective in the treatment of viral warts. We conducted a randomized, patient-blinded, placebo-controlled trial to test the effect of local hyperthermia (44 degrees C for 30 min a day for 3 consecutive days plus 2 additional days 2 weeks later) on plantar warts. By the end of 3 months, 53.57% of patients (15 (...) /28) in the treatment group and 11.54% of patients (3/26) in the control group were cured (P < .01). The effect was not influenced by patient age, duration of disease, or number or size of lesions.

2010 EvidenceUpdates Controlled trial quality: uncertain

9. Treatment of external genital warts and pre-invasive neoplasia of the lower tract. In: Canadian consensus guidelines on human papillomavirus.

Treatment of external genital warts and pre-invasive neoplasia of the lower tract. In: Canadian consensus guidelines on human papillomavirus. Guidelines and Measures | Agency for Healthcare Research & Quality HHS.gov Search ahrq.gov Search ahrq.gov Menu Topics A - Z Healthcare Delivery Latest available findings on quality of and access to health care Searchable database of AHRQ Grants, Working Papers & HHS Recovery Act Projects AHRQ Projects funded by the Patient-Centered Outcomes Research

2009 Society of Obstetricians and Gynaecologists of Canada

10. Interferon for the treatment of genital warts: a systematic review

Interferon for the treatment of genital warts: a systematic review Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2009 DARE.

11. Optimal frequency of imiquimod (Aldara) 5% cream for the treatment of external genital warts in immunocompetent adults: a meta-analysis

Optimal frequency of imiquimod (Aldara) 5% cream for the treatment of external genital warts in immunocompetent adults: a meta-analysis Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2008 DARE.

12. To freeze or not to freeze: a cost-effectiveness analysis of wart treatment

To freeze or not to freeze: a cost-effectiveness analysis of wart treatment To freeze or not to freeze: a cost-effectiveness analysis of wart treatment To freeze or not to freeze: a cost-effectiveness analysis of wart treatment Keogh-Brown M R, Fordham R J, Thomas K S, Bachmann M O, Holland R C, Avery A J, Armstrong S J, Chalmers J R, Howe A, Rodgers S, Williams H C, Harvey I Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED (...) . Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Home-based and primary care treatments for cutaneous warts were compared with the baseline strategies of "spontaneous resolution" (i.e. a do nothing strategy) and basic advice from the general practitioner (GP) without treatment. The home treatments included over-the-counter salicylic acid, duct

2007 NHS Economic Evaluation Database.

13. Topical treatments for cutaneous warts. Full Text available with Trip Pro

Topical treatments for cutaneous warts. Viral warts are common and usually harmless but very troublesome. A very wide range of local treatments are used.To assess the effects of different local treatments for cutaneous, non-genital warts in healthy people.We searched the Cochrane Skin Group Specialised Register (March 2005), the Cochrane Central Register of Controlled Trials (The Cochrane Library Issue 1, 2005), MEDLINE (1966 to March 2005), EMBASE (1980 to March 2005) and a number of other (...) biomedical databases. The references of all trials and selected review articles were also searched. In addition, we contacted pharmaceutical companies involved in local treatments for warts and experts in the fieldRandomised controlled trials of local treatments for cutaneous non-genital viral warts in immunocompetent (healthy) people.Data was extracted and two authors independently selected the trials and assessed methodological quality.Sixty trials were identified that fulfilled the criteria

2006 Cochrane

14. Randomised controlled trial and economic evaluation of podophyllotoxin solution, podophyllotoxin cream, and podophyllin in the treatment of genital warts

Randomised controlled trial and economic evaluation of podophyllotoxin solution, podophyllotoxin cream, and podophyllin in the treatment of genital warts Randomised controlled trial and economic evaluation of podophyllotoxin solution, podophyllotoxin cream, and podophyllin in the treatment of genital warts Randomised controlled trial and economic evaluation of podophyllotoxin solution, podophyllotoxin cream, and podophyllin in the treatment of genital warts Lacey C J, Goodall R L, Tennvall G R (...) , Maw R, Kinghorn G R, Fisk P G, Barton S, Byren I Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The use of podophyllotoxin 0.5% solution and podophyllotoxin 0.15% cream in the treatment of genital warts. Both were self-applied

2003 NHS Economic Evaluation Database.

15. Local treatments for cutaneous warts. (Abstract)

Local treatments for cutaneous warts. Viral warts caused by the human papilloma virus represent one of the most common diseases of the skin. Any area of skin can be affected although the hands and feet are by far the commonest sites. A very wide range of local treatments are available.To assess the effects of different local treatments for cutaneous, non-genital warts in healthy people.We searched the Cochrane Controlled Trials Register (March 1999), the Skin Group trials register (March 1999 (...) ), MEDLINE (1966 to August 2000), EMBASE (1980 to August 2000) and a number of other key biomedical and health economics databases. In addition the cited references of all trials identified and key review articles were searched. Pharmaceutical companies involved in local treatments for warts and experts in the field were contacted.Randomized controlled trials of local treatments for cutaneous non-genital viral warts in immunocompetent human hosts were included.Study selection and assessment

2001 Cochrane

16. Imiquimod for the treatment of genital warts: a quantitative systematic review

Imiquimod for the treatment of genital warts: a quantitative systematic review Imiquimod for the treatment of genital warts: a quantitative systematic review Imiquimod for the treatment of genital warts: a quantitative systematic review Moore R A, Edwards J E, Hopwood J, Hicks D Authors' objectives To review published randomised controlled trials (RCTs) to assess the benefit and harm of imiquimod in the treatment of external genital warts. Searching MEDLINE(from 1966 to December 2000 (...) wart clearance as a measure of treatment efficacy and adverse events. The main outcomes sought were: complete clearance of warts present at the start of treatment; at least 50% reduction in wart area; complete clearance of warts without recurrence; patients withdrawing from the study; and adverse events. How were decisions on the relevance of primary studies made? The authors did not state how the papers were selected for the review, or how many reviewers performed the selection. Assessment

2001 DARE.

17. Genital wart treatments

Genital wart treatments Genital wart treatments Genital wart treatments Anonymous Authors' objectives To assess whether self-administered treatments for anogenital warts are effective. Searching PubMed and the Cochrane Library were searched using the names of the treatments and the subheading of 'randomised controlled trials'. Study selection Study designs of evaluations included in the review Double-blind, randomised controlled trials (RCTs) were included. Specific interventions included (...) was the proportion of patients who had their initial warts completely cleared at the end of the treatment. How were decisions on the relevance of primary studies made? The authors do not state how the papers were selected for the review, other than that they excluded papers after reading the abstracts online. The authors do not state how many of the reviewers performed the selection. Assessment of study quality Validity was assessed using the 3-item, 5-point scale of Jadad et al. (see Other Publications

2000 DARE.

18. The cost effectiveness of patient-applied versus provider-administered intervention strategies for the treatment of external genital warts

The cost effectiveness of patient-applied versus provider-administered intervention strategies for the treatment of external genital warts The cost effectiveness of patient-applied versus provider-administered intervention strategies for the treatment of external genital warts The cost effectiveness of patient-applied versus provider-administered intervention strategies for the treatment of external genital warts Langley P C, Tyring S K, Smith M H Record Status This is a critical abstract (...) , and trichloroacetic acid (TCA)) as second-line therapy for patients failing the patient-applied therapy, in the treatment of external genital warts. Type of intervention Treatment and secondary prevention. Economic study type Cost-effectiveness analysis. Study population Patients with external genital warts. Setting Hospital. The economic study was carried out in the USA. Dates to which data relate Clinical probabilities were obtained from the literature published between 1987 and 1998. The dates of the resource

1999 NHS Economic Evaluation Database.

19. Podophyllin 05% or 20% v podophyllotoxin 05% for the self treatment of penile warts: a double blind randomised study

Podophyllin 05% or 20% v podophyllotoxin 05% for the self treatment of penile warts: a double blind randomised study Podophyllin 05% or 20% v podophyllotoxin 05% for the self treatment of penile warts: a double blind randomised study Podophyllin 05% or 20% v podophyllotoxin 05% for the self treatment of penile warts: a double blind randomised study White D J, Billingham C, Chapman S, Drake S, Jayaweera D, Jones S, Opaneye A, Temple C Record Status This is a critical abstract of an economic (...) evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Treatment for anogenital warts with podophyllin and podophyllotoxin. Type of intervention Treatment. Economic study type Cost-effectiveness analysis. Study population Patients with penile warts. No further details were provided. Setting

1997 NHS Economic Evaluation Database.

20. Patient-applied podofilox for treatment of genital warts. (Abstract)

Patient-applied podofilox for treatment of genital warts. In a double-blind trial, 0.5% podofilox (podophyllotoxin) or placebo was applied by patients to their own genital warts in up to four treatment cycles. At some time during the study, 25 of the 56 podofilox treated patients and none of the 53 placebo group were completely wart-free. At the end of the treatment, 73.6% of the original warts in podofilox treated patients were gone compared with only 8.3% of those in the placebo group (mean (...) percentage of total original wart area was reduced by 82.3% compared with 4.2%). 82% of the treated warts in the podofilox group and 13% in the placebo group had resolved at 6 weeks. Recurrence was observed in 34% of the previously resolved warts. Consistent with this rate of recurrence, new warts developed in a third of the subjects in each group at sites remote from the treatment site. There were no systemic adverse reactions, although transient inflammation, erosion, pain, and burning were common.

1989 Lancet Controlled trial quality: uncertain